Antineoplaston Therapy in Treating Patients With Brain Stem Glioma

Completed · Phase 2

Conditions studied: Brain Stem Gliomas

In brief

RATIONALE: Current therapies for a brain stem glioma provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of brain stem gliomas. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on children (\> 6 months of age) and adults with newly-diagnosed or recurrent brain stem gliomas.

Key facts

Study ID

NCT00003459

Run by

Burzynski Research Institute

People needed

40

Starts

1996-03-01

Expected to finish

2007-09-01

Last updated by the study team

2018-03-14

Who can join

Age: 1 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Burzynski Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.